Match!
Duncan Wilson
UCL Institute of Neurology
643Publications
55H-index
11.5kCitations
Publications 643
Newest
Published on Dec 1, 2019in BMC Medicine8.29
Nick Scott11
Estimated H-index: 11
(Monash University, Clayton campus),
Duncan Wilson55
Estimated H-index: 55
(Monash University, Clayton campus)
+ 5 AuthorsMargaret Hellard48
Estimated H-index: 48
The introduction of highly effective direct-acting antiviral (DAA) therapy for hepatitis C has led to calls to eliminate it as a public health threat through treatment-as-prevention. Recent studies suggest it is possible to develop a vaccine to prevent hepatitis C. Using a mathematical model, we examined the potential impact of a hepatitis C vaccine on the feasibility and cost of achieving the global WHO elimination target of an 80% reduction in incidence by 2030 in the era of DAA treatment. The...
Published on Dec 1, 2019in BMC Neurology2.23
Anupam Datta Gupta3
Estimated H-index: 3
(University of Adelaide),
Renuka Visvanathan22
Estimated H-index: 22
(University of Adelaide)
+ 3 AuthorsDuncan Wilson55
Estimated H-index: 55
(University of Adelaide)
Background Post-stroke lower limb spasticity (PSLLS) has a prevalence of 28–37%. PSLLS can cause difficulty in walking and reduce quality of life (QOL). Post stroke spasticity impairs the ability to intervene to improve walking ability. Botulinum Toxin A (BT) is an effective intervention for focal spasticity, but its use is currently restricted in many countries by their reimbursement system stating that the evidence for improvement in walking and quality of life (QOL) is not robust for treatmen...
Published on Sep 4, 2019in Liver International5.54
E. Sophia Schroeder (Monash University), Alisa Pedrana12
Estimated H-index: 12
(Monash University)
+ 26 AuthorsManal Hamdy El-Sayed15
Estimated H-index: 15
(Ain Shams University)
Published on Oct 1, 2019in AIDS4.50
Robyn M. Stuart3
Estimated H-index: 3
,
Sherrie L. Kelly7
Estimated H-index: 7
+ 2 AuthorsDuncan Wilson55
Estimated H-index: 55
Published on Jul 1, 2019in AIDS4.50
Debra ten Brink , Rowan Martin-Hughes3
Estimated H-index: 3
+ 1 AuthorsDuncan Wilson55
Estimated H-index: 55
Published on May 1, 2019in Lancet Neurology28.75
Duncan Wilson55
Estimated H-index: 55
,
Gareth Ambler25
Estimated H-index: 25
(UCL: University College London)
+ 307 AuthorsHugues Chabriat (French Institute of Health and Medical Research)
Summary Background Cerebral microbleeds are a neuroimaging biomarker of stroke risk. A crucial clinical question is whether cerebral microbleeds indicate patients with recent ischaemic stroke or transient ischaemic attack in whom the rate of future intracranial haemorrhage is likely to exceed that of recurrent ischaemic stroke when treated with antithrombotic drugs. We therefore aimed to establish whether a large burden of cerebral microbleeds or particular anatomical patterns of cerebral microb...
Published on Jul 1, 2019in Neurobiology of Aging4.40
Isabel Charlotte Hostettler1
Estimated H-index: 1
(UCL: University College London),
Manuel Bernal-Quiros + 13 AuthorsTarek A. Yousry60
Estimated H-index: 60
Abstract The C9orf72 GGGGCC repeat expansion has been associated with several diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD). It has also been associated with increased white matter changes in FTD as well as risk of cognitive impairment in ALS. Dementia is common both before and after intracerebral haemorrhage (ICH). Since the mechanisms of cognitive impairment in patients with ICH are uncertain, we investigated whether C9orf72 could influence dementia ris...
12345678910